Recursion Provides Business Updates and Reports Fourth

Initiated five clinical trials in 2022, including three Phase 2 programs, and provided guidance on the timing of clinical data readoutsDelivered against...

Related Keywords

Montreal ,Quebec ,Canada ,Salt Lake City ,Utah ,United States ,Toronto ,Ontario ,Chris Gibson ,Development Expenses ,Recursion Pharmaceuticals Inc ,Chemical Technology ,Recursion Co ,Cavernous Malformation ,Adenomatous Polyposis ,Proficient Ovarian Cancer ,Target Gamma ,Inhibiting Novel Targets ,Target Alpha ,Tissue Culturing ,Available Dataset ,Recursion Co Founder ,Download Day ,Shareholder Meeting ,Recursion Annual Shareholder Meeting ,Fiscal Year ,Administrative Expenses ,San Francisco Bay ,Recursion Pharmaceuticals ,Biotechnology ,Health Pharmaceuticals ,Inance Biotech Industry ,Technology General ,